Literature DB >> 18224732

Available biological treatments for complex non-unions.

A Mahendra1, A D Maclean.   

Abstract

The treatment of complex non-unions may be lengthy and very expensive. The majority of aseptic non-union cases require a variable degree of biological enhancement. Autologous iliac crest bone graft remains the gold standard of treatment. However, other means of biological stimulation are currently available in the armamentarium of the treating physician. This review article reports on the different available biological treatment options for the management of complex aseptic bone non-unions.

Mesh：

Substances：

Year:  2007        PMID： 18224732     DOI： 10.1016/s0020-1383(08)70004-4

Source DB:  PubMed          Journal:  Injury        ISSN： 0020-1383            Impact factor:   2.586


  21 in total

1.  [Platelet-rich plasma combined with autologous cancellous bone : An alternative therapy for persistent non-union?].

Authors:  M Hakimi; P Jungbluth; S Thelen; M Betsch; W Linhart; S Flohé; J Windolf; M Wild
Journal:  Unfallchirurg       Date:  2011-11       Impact factor: 1.000

Review 2.  [Tissue engineering of bone tissue. Principles and clinical applications].

Authors:  B Schmidt-Rohlfing; C Tzioupis; C L Menzel; H C Pape
Journal:  Unfallchirurg       Date:  2009-09       Impact factor: 1.000

3.  Long-term safety and efficacy of human bone morphogenetic protein (HBMP) in the treatment of resistant non-unions and failed arthrodesis.

Authors:  Arya Nick Shamie; Hamed Yazdanshenas; Eric Egan Johnson
Journal:  J Clin Orthop Trauma       Date:  2016-11-16

4.  MC3T3-E1 osteoprogenitor cells systemically migrate to a bone defect and enhance bone healing.

Authors:  Emmanuel Gibon; Barbara Batke; Muhammad Umar Jawad; Kate Fritton; Allison Rao; Zhenyu Yao; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-01-04       Impact factor: 3.845

5.  Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing.

Authors:  Timothy J Myers; Yun Yan; Froilan Granero-Molto; Jared A Weis; Lara Longobardi; Tieshi Li; Ying Li; Clara Contaldo; Huseyin Ozkan; Huseyin Ozkhan; Anna Spagnoli
Journal:  Growth Factors       Date:  2012-05-04       Impact factor: 2.511

6.  Gene expression dynamics during bone healing and osseointegration.

Authors:  Zhao Lin; Hector F Rios; Sarah L Volk; James V Sugai; Qiming Jin; William V Giannobile
Journal:  J Periodontol       Date:  2010-12-13       Impact factor: 6.993

7.  Evaluation of the effects of nano-TiO2 on bioactivity and mechanical properties of nano bioglass-P3HB composite scaffold for bone tissue engineering.

Authors:  Sanaz Soleymani Eil Bakhtiyari; Saeed Karbasi; Ahmad Monshi; Mahbobeh Montazeri
Journal:  J Mater Sci Mater Med       Date:  2015-11-26       Impact factor: 3.896

8.  Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases.

Authors:  Y-K Lee; Y-C Ha; K-H Koo
Journal:  Osteoporos Int       Date:  2012-10-18       Impact factor: 4.507

Review 9.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today.

Authors:  Ippokratis Pountos; Theodora Georgouli; George Kontakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2010-02       Impact factor: 3.075

10.  Successful treatment of sternal fracture nonunion with teriparatide.

Authors:  S Chintamaneni; K Finzel; B L Gruber
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.